Top headlines: Moody's upgrades TaMo outlook; Sputnik V launched in India

Business Standard brings you stories that made the headlines on Friday

Sputnik V, Dr Reddy's Laboratories, DRL, coronavirus, vaccine, covid-19
Sputnik V vaccine
BS Web Team New Delhi
2 min read Last Updated : May 14 2021 | 6:35 PM IST
Dr Reddy's launches Sputnik V vaccine in India
 
Drug firm Dr Reddy's Laboratories on Friday said it has launched COVID vaccine Sputnik V in the Indian market with the first dose being administered in Hyderabad, as part of a limited pilot. The company said the imported doses of the vaccine are presently priced at a maximum retail price of Rs 948, with 5 per cent GST per dose, amounting to Rs 995.4 per dose. READ MORE...

Moody’s upgrades outlook on Tata Motors
 
Credit rating agency, Moody's Investors Service, has upgraded its outlook on Tata Motors to stable from negative and affirmed the company's B1 corporate family rating (CFR) and B1 senior unsecured ratings. The latest rating action follows Moody's affirmation and change in outlook to stable from negative on the B1 ratings of the company's UK subsidiary Jaguar Land Rover Automotive Plc (JLR) earlier this week. READ MORE...

Escorts Q4 net profit jumps two-fold

Farm equipment and engineering major Escorts Ltd on Friday reported over two-fold jump in consolidated net profit to Rs 285.41 crore in the fourth quarter ended March 2021, mainly driven by robust sales. The company had posted a consolidated net profit of Rs 127.73 crore in the same period previous fiscal, Escorts Ltd said in a regulatory filing. READ MORE...

Govt working in war-footing mode

Stating that the country is fighting an invisible enemy, Prime Minister Narendra Modi on Friday said the government is working in war-footing mode to fight the second wave of COVID-19 and expressed confidence in winning the battle. Addressing a video conference on PM-KISAN scheme, the Prime Minister said 18 crore doses of Covid-19 vaccines have been given so far and the government is making efforts to ensure that people get vaccinated at a fast pace. READ MORE...

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCurated ContentNewstop events of the daytop news of the dayToday NewsMoodysCoronavirus VaccineTata MotorsQ4 ResultsEscorts Ltd

Next Story